Drug and pharmaceutical recalls

Dukal BZK Antiseptic Towelettes were manufactured without meeting federal quality standards (CGMP deviations). Affected lots were distributed nationwide. No injuries have been reported.

First Aid Only BZK Antiseptic Towelettes (50-count packages) are being recalled because the manufacturer did not follow required quality and safety procedures during production. The recall affects specific lot numbers distributed nationwide. No injuries have been reported.

First Aid Only BZK Antiseptic Towelettes have been recalled due to manufacturing quality control deviations. The FDA determined that certain lots did not meet required manufacturing standards. No injuries have been reported to date.

Teva Pharmaceuticals is recalling specific lots of metoprolol succinate extended-release 200 mg tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This could affect how well the blood pressure medication works. No injuries have been reported.

Teva Pharmaceuticals is recalling specific batches of Metoprolol Succinate Extended-Release 100 mg tablets because they may not dissolve properly in the body. This means the medication may not work as intended. The recall affects bottles with lot numbers ending in J251 or J252 and expiration dates of 12/2026.

Teva Pharmaceuticals is recalling certain batches of Metoprolol Succinate Extended-Release 50 mg tablets because they may not dissolve properly in the body, which could affect how well the medication works. The affected bottles have specific lot numbers and an expiration date of January 2027. No injuries have been reported.

Teva Pharmaceuticals is recalling specific lots of Metoprolol Succinate Extended-Release 25 mg tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This could result in the drug not working as intended. No injuries have been reported.

BioGlo Fluorescein Sodium Ophthalmic Strips were not manufactured according to safety standards, raising concerns about sterility. The strips are used by eye care professionals for diagnostic eye exams. All lots distributed nationwide are affected.

Bio Glo Fluorescein Sodium Ophthalmic Strips USP were not manufactured following proper sterility standards. These diagnostic strips, distributed nationwide, may not be sterile and could pose a safety risk if used in the eye.

Wizcure Fluorescein Sodium Ophthalmic Strips (1mg) were not manufactured following proper sterilization standards. These strips are used by eye care professionals to examine the eye surface. Because sterility cannot be assured, there is a potential risk of contamination.

Vista Gonio Eye Lubricant (hypromellose ophthalmic solution) distributed by hi-health was not manufactured following required safety standards, raising concerns about sterility. All lots of this eye drop product are affected. No injuries have been reported to date.

Vista Meibo Tears Propylene Glycol 0.6% eye drops were not manufactured under proper safety conditions, raising concerns about sterility. The FDA issued a recall of all lots distributed nationwide. No injuries have been reported.

Vista Gel Hypromellose eye drops were not manufactured according to FDA safety standards, which means the product may not be sterile. The eye drops were distributed nationwide in the United States. No injuries have been reported.

Vista Tears eye drops were manufactured without proper sterility controls, which means they may not be safe for use in the eye. No injuries have been reported, but the product does not meet FDA safety standards.

Agebox iKids-Growth Night Formula contains ibutamoren, a substance not listed on the label or approved by the FDA for this product. The affected 60-count bottles were sold online through Agebox.com and Amazon.com. No injuries have been reported.

Agebox iKids-Growth Day Formula capsules contain an undeclared drug ingredient called ibutamoren that was not approved by the FDA. The product was sold without proper FDA authorization. This affects 60-count bottles with lot numbers 23101201, 24080801, and 25020701.

Slate Run Pharmaceuticals is recalling Eptifibatide Injection 75 mg/100 mL vials because the carton label says "weight-adjusted bolus dosing" when it should say "weight-adjusted infusion." This labeling error could lead to incorrect administration of the medication. No injuries have been reported.

AvKARE is recalling one lot of Amantadine HCl 100 mg capsules because they failed to meet dissolution specifications—meaning the capsules may not break down properly in the body, affecting how much medicine you receive. This is a quality issue identified during manufacturing testing. No injuries have been reported.

LEO Pharma is recalling specific lots of Adbry, a prescription injection used to treat atopic dermatitis, because one unit was found to contain wool fiber particles. This contamination raises concerns about sterility and safety. No injuries have been reported so far.

McKesson's UDENYCA (pegfilgrastim-cbqv) injection was stored at room temperature instead of in the refrigerator, which may have reduced its effectiveness. This affected 116 cartons from Lot 2199821 with specific serial numbers. The FDA classified this as a Class I recall.

Meitheal Pharmaceuticals is recalling Cetrorelix Acetate 0.25 mg injection kits because some contain missing or duplicated needles in the delivery system. This affects lot Q4E0112A with an expiration date of April 30, 2027. The defect could prevent proper injection or cause unsafe handling.

American Health Packaging is recalling certain oxycodone hydrochloride 5 mg tablets because the blister card seals are defective or missing. This allows tablets to fall out of their compartments. The recall affects 31,676 packages distributed nationwide with specific lot numbers and expiration dates.

Fresenius Kabi Compounding has recalled vancomycin HCl 2-gram doses mixed in sodium chloride solution due to concerns that sterility cannot be assured. The affected lots were distributed nationwide. This is a serious issue because non-sterile injectables can cause life-threatening infections.

Fresenius Kabi Compounding issued a recall of vancomycin HCl 1.5 grams in 500 mL sodium chloride solution due to lack of assured sterility. The affected lot (C274-000049628, expiring May 3, 2026) was distributed nationwide to healthcare facilities. No injuries have been reported.

Fresenius Kabi Compounding has recalled multiple lots of thiamine HCl 500 mg injection because the manufacturer cannot confirm the product is sterile. This injectable medication was distributed nationwide. The recall affects 10,548 bags with expiration dates between February and May 2026.

Fresenius Kabi Compounding has recalled five specific lots of ketamine HCl injection (10 mg per mL) distributed nationwide because the manufacturer cannot confirm the product remains sterile. The affected lots were produced between February and April 2026.

Fresenius Kabi Compounding has recalled acyclovir sodium 200 mg IV injection bags because the manufacturer cannot guarantee the product is sterile. The affected bags were produced by Fagron Sterile Services and have lot number C274-000049124 with an expiration date of February 28, 2026. No infections or injuries have been reported so far.

Asteria Health is recalling specific lots of testosterone 100mg/anastrozole 4mg sterile pellets due to potential metal particulate matter in the product. The contamination was discovered during quality testing. No injuries have been reported.

Asteria Health has recalled a specific lot of testosterone and triamcinolone acetonide pellets because they may contain metal particulate matter. This contamination was discovered during manufacturing. The affected lot is 256000103, which expires July 28, 2026.

Asteria Health is recalling a hormone medication pellet containing testosterone and triamcinolone due to the potential presence of metal particulate matter in the product. The recall affects lot 256000105 with an expiration date of September 19, 2026, distributed nationwide. No injuries have been reported.